20 avr.: VRANKEN-POMMERY MONOPOLE : CHIFFRE D'AFFAIRE DU 1er TRIMESTRE 201..
23 avr.: RHJ International : Déclaration de transparence - Notification : ..
23/04/2012 05:30:00

CORRECT: Australia's Biota, Nabi Pharmaceuticals Plan Merger

Related content

("Australia's Biota, Nabi Pharmaceuticals Plan Merger," at 2313 GMT, misstated the return to shareholders in the final paragraph. The correct version follows:)

MELBOURNE -(Dow Jones)- Australian drug development company Biota Holdings Ltd. (BTA.AU) said Monday it plans to merge with Nabi Biopharmaceuticals (NABI) to form a combined company to be listed on Nasdaq.

Biota said in a statement the move to the U.S. was designed to achieve better value recognition and liquidity through a stronger U.S. shareholder base.

"We believe this is a necessary step to increase our options for the development and commercialization of our product portfolio and will ultimately improve the recognition of the underlying value of our product portfolio for our shareholders," said Biota Chairman Jim Fox.

Biota develops anti influenza drugs such as Relenza, which is marketed by GlaxoSmithKline PLC.

Under the merger, Nabi will acquire all the shares in Biota for new shares in the name of Biota Pharmaceuticals, a Nasdaq listed company. Biota shareholders will own about 74% of Biota Pharmaceuticals and Nabi shareholders will own about 26% of the company.

Under the proposed merger Nabi will bring US$54 million to the new company, and excess cash, estimated to be around US$30 million, would be returned to existing Nabi shareholders.

-By Gavin Lower, Dow Jones Newswires; 61-3-9292-2095; gavin.lower@dowjones.com

(END) Dow Jones Newswires

April 22, 2012 23:30 ET (03:30 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

20 avr.: VRANKEN-POMMERY MONOPOLE : CHIFFRE D'AFFAIRE DU 1er TRIMESTRE 201..
23 avr.: RHJ International : Déclaration de transparence - Notification : ..

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
Ingen indlæg

Annonces

Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine
1
Crédit Agricole Ille-et-Vilaine : MAD rapport semestriel au 30 juin 2015
2
Nicox : Activité du premier semestre 2015
3
Valeo annonce un investissement de 22 millions d'euros dans le fonds franco-chinois Innovation de Cathay Capital
4
CREDIT AGRICOLE NORD DE FRANCE : Mise à disposition du rapport financier semestriel au 30 juin 2015
5
Hermès International : Résultats 1er semestre 2015

Related stock quotes

GlaxoSmithKline PLC 1 340,50 0,7% Cours en hausse
GlaxoSmithKline PLC 41,25 0,1% Cours en hausse

Buy and sell signals

  • Tendance
  • Moneymachine
Acheter
Acheter
Acheter
Vendre
Vendre
Vendre

Droit d'auteur Euroinvestor A/S 2015   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Interactive Data.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
 
samedi 29 août 2015 02:12:45
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20150824.1 - EUROWEB3 - 2015-08-29 02:12:45 - 2015-08-29 02:12:45 - 4 - Website: OKAY